# NeoMed: portfolio, investments and team

> NeoMed is a growth equity based in United States. 28 investments on record, latest Sept 2017. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/neomed (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# NeoMed

Last cheque observed Sep 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet Growth equity

Series C Series B Venture Biotechnology Health Care Venture Capital & Private Equity

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 28 on record

Since the last cheque **3325** days **00** hrs **00** min **00** sec

Median round **$46M** Rounds led **0 of 28** Sole investor **1 rounds** Exits **3 from the portfolio** Mostly in **United States, 32%**

Pitch NeoMed

## NeoMed highlights

- 01 28 rounds on record
- 02 Mostly Series C and Series B: 59% of its rounds
- 03 Sole investor in 1 rounds, median $4.7M
- 04 3 exits from the portfolio

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Biotechnology Health Care Venture Capital & Private Equity
- **Based in:** Rootstown, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **28 appearances**

- **2017** 3 rounds
- **Sept** **[Sonendo](https://millionrounds.com/company/sonendo)** US · FinSMEs **$50M** With 5 others
- **May** **[Axionics](https://millionrounds.com/company/axionics)** Series C · US · FinSMEs **$15M** With 3 others
- **Apr** **[Arsanis](https://millionrounds.com/company/arsanis)** Series D · US · FinSMEs **$46M** With 6 others
- **2015** 4 rounds
- **Oct** **[Sequana Medical](https://millionrounds.com/company/sequana-medical)** Series C · CH **$9.3M** With 5 others
- **Aug** **[JenaValve Technology](https://millionrounds.com/company/jenavalve-technology)** Series C · DE **$27M** With 7 others
- **Aug** **[Avitide](https://millionrounds.com/company/avitide)** Series C · US **$7.6M** With 4 others
- **Jan** **[Genkyotex](https://millionrounds.com/company/genkyotex)** Series D · CH **$21M** With 5 others
- **2014** 5 rounds
- **Sept** **[Sonendo](https://millionrounds.com/company/sonendo)** Series D · US **$35M** With 3 others
- **Apr** **[Wilson Therapeutics](https://millionrounds.com/company/wilson-therapeutics)** Series B · SE **$40M** With 3 others
- **Apr** **[JenaValve Technology](https://millionrounds.com/company/jenavalve-technology)** Series C · DE **$10M** With 8 others
- **Feb** **[InDex Pharmaceuticals](https://millionrounds.com/company/index-pharmaceuticals)** Growth · SE **$20M** With 2 others
- **Jan** **[TopiVert](https://millionrounds.com/company/topivert)** Venture · GB **$6.8M** With 3 others
- **2013** 4 rounds
- **Sept** **[Arsanis](https://millionrounds.com/company/arsanis)** Series B · AT · biospace.com **$20M** With 3 others
- **Jul** **[JenaValve Technology](https://millionrounds.com/company/jenavalve-technology)** Series C · DE · finsmes.com **$63M** With 7 others
- **Jun** **[Diagnoplex](https://millionrounds.com/company/diagnoplex)** Venture · CH · finsmes.com **$1.4M** With 2 others
- **Jun** **[Sonendo](https://millionrounds.com/company/sonendo)** Series C · US · finsmes.com **$18M** With 4 others
- **2012** 2 rounds
- **Nov** **[Endosense](https://millionrounds.com/company/endosense)** Series C · CH · finsmes.com **$40M** With 7 others
- **Jun** **[Sonendo](https://millionrounds.com/company/sonendo)** Series C · US · pevc.dowjones.com **$9.2M** With 2 others
- **2011** 2 rounds
- **Aug** **[Vessix Vascular](https://millionrounds.com/company/vessix-vascular)** Series B · US · finsmes.com **$23M** With 3 others
- **Mar** **[NovaShunt](https://millionrounds.com/company/novashunt)** Series B · CH · prnewswire.com **$25M** With 4 others
- **2010** 1 round
- **Oct** **[Vessix Vascular](https://millionrounds.com/company/vessix-vascular)** Venture · US · hedgehogs.net **$4.7M** Sole investor
- **2009** 1 round
- **Oct** **[Endosense](https://millionrounds.com/company/endosense)** Series B · CH · onbiovc.com **$36M** With 6 others
- **2008** 2 rounds
- **Dec** **[Diagnoplex](https://millionrounds.com/company/diagnoplex)** Series A · CH · bio-medicine.org **$8.3M** With 1 other
- **Jun** **[Creabilis](https://millionrounds.com/company/creabilis)** Series A · GB **$31M** With 1 other
- **2007** 2 rounds
- **Dec** **[PregLem](https://millionrounds.com/company/preglem)** Series B · GB **$32M** With 2 others
- **Jun** **[PregLem](https://millionrounds.com/company/preglem)** Series A · GB **$26M** With 2 others
- **2005** 2 rounds
- **Oct** **[Kuros Biosurgery](https://millionrounds.com/company/kuros-biosurgery)** Venture · CH · kuros.ch **$4.3M** With 5 others
- **Jan** **[Kuros Biosurgery](https://millionrounds.com/company/kuros-biosurgery)** Series B · CH · kuros.ch **$5.4M** With 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## Exits from the portfolio

Companies it backed that were later bought or listed **3 in all**

**[Endosense](https://millionrounds.com/company/endosense)** Bought by [St. Jude Medical](https://millionrounds.com/fund/st-jude-medical) **$170M** Aug 2013

**[Vessix Vascular](https://millionrounds.com/company/vessix-vascular)** Bought by [Boston Scientific](https://millionrounds.com/fund/boston-scientific) **$300M** Nov 2012

**[PregLem](https://millionrounds.com/company/preglem)** Bought by [Richter Group](https://millionrounds.com/fund/richter-group) **Undisclosed** Oct 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series C Series B Venture

Median round joined **$46M** the round, not its cheque Alone, median **$4.7M**

Led 0 of 28 rounds **0%**

- **Sole investor:** 1 rounds
- **Last cheque:** Sept 2017
- **Exits:** 3 from the portfolio

Rounds by stage said on their site

- Series C *9*
- Series B *7*
- Venture *4*
- Series A *3*
- Series D *3*
- Growth *1*

Cheques by year Led Joined

2005 2017

Often in the room with

- [VI Partners](https://millionrounds.com/fund/vi-partners) 10
- [OrbiMed](https://millionrounds.com/fund/orbimed) 8
- [Edmond de Rothschild Venture Capital](https://millionrounds.com/fund/edmond-de-rothschild-venture-capital) 5
- [Gimv](https://millionrounds.com/fund/gimv) 5
- [Legend Capital](https://millionrounds.com/fund/legend-capital) 4
- [Atlas Venture](https://millionrounds.com/fund/atlas-venture) 3

**Pitching NeoMed?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as NeoMed. A count of rooms they were both in, not a relationship either has claimed.

[**VI Partners** VC firm **10** rounds together](https://millionrounds.com/fund/vi-partners)[**OrbiMed** Private equity **8** rounds together](https://millionrounds.com/fund/orbimed)[**Edmond de Rothschild Venture Capital** Growth equity **5** rounds together](https://millionrounds.com/fund/edmond-de-rothschild-venture-capital)[**Gimv** Private equity **5** rounds together](https://millionrounds.com/fund/gimv)[**Legend Capital** VC firm **4** rounds together](https://millionrounds.com/fund/legend-capital)[**Atlas Venture** VC firm **3** rounds together](https://millionrounds.com/fund/atlas-venture)[**DEFI Gestion SA** Investment firm **3** rounds together](https://millionrounds.com/fund/defi-gestion-sa)[**Fjord Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/fjord-ventures)[**MVM Life Science Partners** VC firm **3** rounds together](https://millionrounds.com/fund/mvm-life-science-partners)[**SV Life Sciences** VC firm **3** rounds together](https://millionrounds.com/fund/sv-life-sciences)[**Sofinnova Partners** VC firm **3** rounds together](https://millionrounds.com/fund/sofinnova-partners)[**Declaration Partners** Family office **2** rounds together](https://millionrounds.com/fund/declaration-partners)

## Recently backed

The latest companies NeoMed put money into.

[**Sonendo** $50M · Sept 2017](https://millionrounds.com/company/sonendo)[**Arsanis** $46M · Apr 2017](https://millionrounds.com/company/arsanis)

## Quick answers about NeoMed

### What does NeoMed invest in?

NeoMed invests most often at Series C and Series B (59% of the rounds on record), in sectors such as Biotechnology, Health Care and Venture Capital & Private Equity.

### How active is NeoMed?

28 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2017.

### What has NeoMed invested in recently?

Its most recent investments on record: Sonendo (Undisclosed round, Sept 2017), Axionics (Series C, May 2017) and Arsanis (Series D, Apr 2017).

### How big are NeoMed's cheques?

The median round it joins is $46M.

### Does NeoMed lead rounds?

Rarely, if at all: none of its 28 investments on record names it as the lead.

### Where does NeoMed invest?

Most of the companies it backs are in the United States (32%), Switzerland (32%) and the United Kingdom (14%).

### Is NeoMed investing now?

No investments in the last 12 months; the latest was in Sept 2017.

### Who does NeoMed invest alongside?

Most often VI Partners (10 rounds together), OrbiMed (8 rounds together) and Edmond de Rothschild Venture Capital (5 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=neomed) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=neomed)